Welcome to our dedicated page for Neogen news (Ticker: NEOG), a resource for investors and traders seeking the latest updates and insights on Neogen stock.
Neogen Corporation (NASDAQ: NEOG) provides essential solutions for food safety and animal health through advanced diagnostic technologies. This page serves as the definitive source for official company news, offering investors and industry professionals timely updates on developments impacting global food security and veterinary practices.
Access curated press releases and announcements covering financial results, product launches, strategic partnerships, and regulatory milestones. Our aggregation ensures you stay informed about NEOG's innovations in pathogen detection, molecular testing platforms, and biosafety initiatives without needing to monitor multiple sources.
All content is verified for accuracy and relevance, providing a trustworthy resource for understanding Neogen's market position and technological advancements. Key updates include progress in genomic testing, international expansion efforts, and collaborations with agricultural regulators.
Bookmark this page or check back regularly for unfiltered access to Neogen's corporate communications and critical updates that shape the future of food and animal safety industries.
Neogen (NASDAQ: NEOG) announced its fourth-quarter 2024 results, reporting revenue of $236.8 million, a 2.1% decrease from the prior year. The company reported a net loss of $5.4 million, or $(0.02) per diluted share, compared to net income of $5.6 million in the prior-year period. Adjusted Net Income was $22.4 million, or $0.10 per diluted share.
For the full fiscal year 2024, Neogen reported revenue of $924.2 million, a 12.4% increase from the previous year. The company's Adjusted EBITDA for the fourth quarter was $53.0 million, representing a margin of 22.4%. Neogen's CEO, John Adent, noted progress in integration efforts and improvement in order fulfillment rates, despite soft end-market conditions.
Neogen (NASDAQ: NEOG) has announced it will release its fourth-quarter earnings report on Tuesday, July 30, 2024, before the market opens. A webcast and conference call will follow at 8:00 a.m. Eastern time, where executives will discuss the financial results. Interested parties can access the call by dialing (800) 836-8184 (U.S.) or +1 (646) 357-8785 (international) and requesting the Neogen Fourth Quarter 2024 Earnings Call. The live webcast will be available on Neogen's Investor Relations webpage under the 'Events & Presentations' subheading. A replay of the conference call and webcast will be available shortly after the event via the same Investor Relations webpage or by dialing (888) 660-6345 (U.S.) or +1 (646) 517-4150 (international) and using the entry code 82704.
Neogen announced the launch of its Petrifilm® Automated Feeder on June 27, 2024. This system is designed to enhance the efficiency of high-throughput food safety testing by reducing manual tasks. The feeder automates the loading and counting of Petrifilm Plates, processing up to 300 plates in 33 minutes, a significant improvement from the previous 4-hour manual process. The system integrates seamlessly with existing Petrifilm Plate Reader Advanced equipment and lab workflows, helping labs meet food safety standards more efficiently. Preliminary trials have shown a high return on investment and improved lab productivity.
Neogen (NASDAQ: NEOG) announced that its Molecular Detection System has been selected by the USDA Food Safety and Inspection Service (FSIS) as the primary method for detecting Salmonella and Listeria monocytogenes in meat, poultry, and egg products. The USDA FSIS has trusted Neogen's system for over five years due to its reliability and efficiency. The new contract also includes Listeria spp. and the Neogen Molecular Detection Assay 2 for Salmonella Enteritidis and Salmonella Typhimurium. Neogen's system utilizes LAMP technology for fast and accurate pathogen detection and can conduct up to 96 tests simultaneously across various sample types. This recognition underscores Neogen's commitment to global food security.
Neogen has launched CelluSmart technology through Megazyme for measuring cellulosic ethanol in biofuel production. This innovation improves upon the NREL procedure with a yeast-degrading cocktail, enhancing the production of low-carbon fuels. Cellulosic ethanol can reduce greenhouse gas emissions by 60% compared to petroleum-based fuels, promoting progress toward climate goals. CelluSmart technology can help ethanol producers lower carbon intensity scores, potentially opening new markets such as sustainable aviation fuel. The technology is incorporated into ASTM Method E-3417-24, fulfilling EPA's approval requirements for a method from a voluntary consensus standards body.
Neogen (NASDAQ: NEOG), a leader in food safety solutions, announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. This event will take place in Miami, Florida, on June 12, 2024. The company's involvement in such a prestigious event highlights its standing in the healthcare sector and offers an opportunity to present its latest innovations and business strategies to a global audience.
Neogen (NASDAQ: NEOG) announced its participation in the 44th Annual William Blair Growth Stock Conference on June 4, 2024, in Chicago, Illinois. John Adent, the company's President and CEO, will present at 8:00 a.m. Central Time. The presentation materials will be available on Neogen's Investor Relations website on the same day. Investors and interested parties can access the webcast and materials through the Events & Presentations section at neogen.com/investor-relations/events-presentations.
Neogen (NASDAQ: NEOG) will participate in the Bank of America 2024 Health Care Conference in Las Vegas, Nevada, on May 15, 2024.
Neogen (NEOG) will participate in the 2024 RBC Capital Markets Global Healthcare Conference in New York. John Adent, the CEO, will present on May 14, 2024, at 4:05 PM Eastern Time. Investors can access the webcast and presentation materials on Neogen's Investor Relations website.
Neogen® (NASDAQ: NEOG) is celebrating 40 years of Petrifilm, a groundbreaking solution that has revolutionized microbiological testing in the food safety industry. With over 2.85 billion plates used worldwide and 105+ global validations, Petrifilm has significantly increased productivity, reduced testing time, and saved space in laboratories. Neogen remains committed to providing high-quality, innovative solutions to maintain its position as a global leader in food safety.
